"Smoker's Paradox" in Patients Treated for Severe Injuries: Lower Risk of Mortality After Trauma Observed in Current Smokers.
"Smoker's Paradox" in Patients Treated for Severe Injuries: Lower Risk of Mortality After Trauma Observed in Current Smokers.
复制标题
接受严重损伤治疗的患者的“吸烟者悖论”:在当前吸烟者中观察到的创伤后死亡风险较低。
DOI:
10.1093/ntr/ntv027
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
Zarzaur,BenL
中科院分区:
文献类型:
--
作者:
Bell,TeresaM;Bayt,DemetriaR;Zarzaur,BenL
BackgroundStudies evaluating the effect of smoking status on mortality outcomes in trauma patients have been limited, despite the fact that survival benefits of smoking have been reported in other critical care settings. The phenomenon “smoker’s paradox” refers to the observation that following acute cardiovascular events, such as acute myocardial infarction and cardiac arrest, smokers often experience decreased mortality in the hospital setting. The objective of our study was to determine whether smoking imparts a survival benefit in patients with traumatic injuries.MethodsWe performed a retrospective cohort study that analyzed cases included in the National Trauma Data Bank research dataset. Hierarchical logistic regression analyses were used to determine whether smoking alters the risk of mortality and complications in patients who smoke.ResultsThe percentage of patients experiencing mortality differed significantly between smokers (n= 38,564) and nonsmokers (n= 319,249) (1.8% vs. 4.3%,P< .001); however, the percentage experiencing a major complication did not (9.7% vs. 9.6%,P= .763). Regression analyses indicated that smokers were significantly less likely to die during the hospital stay compared to nonsmokers after adjusting for individual and hospital factors (OR= 0.15; CI = 0.10, 0.22). Additionally, smokers were also less likely to develop a major complication than nonsmokers (OR= 0.73, CI = 0.59–0.91).ConclusionsPatients who smoke appear to have a much lower risk of in-hospital mortality than nonsmokers. Further investigation into biological mechanisms responsible for this effect should be carried out in order to potentially develop therapeutic applications.
登录
查看更多内容
DOI:
10.1177/107602960401000314
发表时间:
2004
期刊:
Clinical and Applied Thrombosis/Hemostasis
影响因子:
--
作者:
J. Suwansaksri;V. Wiwanitkit;S. Soogarun
通讯作者:
S. Soogarun
DOI:
10.1097/ta.0b013e31816335ae
发表时间:
2008-02-01
影响因子:
--
作者:
Kardooni, Shahrzad;Haut, Elliott R.;Cornwell, Edward E., III
通讯作者:
Cornwell, Edward E., III
影响因子:
3.8
作者:
Samantha Tarras;L. Diebel;D. Liberati;Kevin R. Ginnebaugh
通讯作者:
Samantha Tarras;L. Diebel;D. Liberati;Kevin R. Ginnebaugh
影响因子:
4
作者:
P. Kievit;M. Brouwer;G. Veen;W. Aengevaeren;F. Verheugt
通讯作者:
F. Verheugt
影响因子:
4
作者:
B. Angeja;S. Kermgard;Michael S. Chen;Matthew Mckay;S. Murphy;E. Antman;Christopher P. Cannon;E. Braunwald;C. Gibson
通讯作者:
C. Gibson